Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (61-70 of 195) with videos related to

Pageof 20
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Individualizing treatment to optimize survival outcomes in breast cancerEdith A Perez, William J Gradishar, Christopher Twelves, et al.
Expert Review of Anticancer Therapy|September 12, 2015
Breast cancer and immunology: biomarker and therapeutic developmentsCesar A Santa-Maria, Sue Jung Park, Sarika Jain, et al.
Clinical Advances in Hematology & Oncology : H&O|May 30, 2014
Clinical roundtable monograph: effective management of quality of life in metastatic breast cancerTwelves Christopher, William J Gradishar, Joyce A O'Shaughnessy, et al.
The New England Journal of Medicine|September 26, 2008
Case records of the Massachusetts General Hospital. Case 30-2008. A 47-year-old woman with a mass in the breast and a solitary lesion in the spineWilliam J Gradishar, Jennifer R Bellon, Michele A Gadd, et al.
Oncology (Williston Park, N.Y.)|February 20, 2016
Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?Cesar Augusto Santa-Maria, Lauren Nye, Martin B Mutonga, et al.
Journal of Oncology Practice|November 28, 2012
Barriers to the use of personalized medicine in breast cancerChristine B Weldon, Julia R Trosman, William J Gradishar, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancerJulia R Trosman, Christine B Weldon, Julian C Schink, et al.
Cancer|September 10, 2008
Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancerHannah W Hazard, Seema R Gorla, Denise Scholtens, et al.
Journal of the National Cancer Institute|July 7, 2012
Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic reviewJohn Hornberger, Michael D Alvarado, Chien Rebecca, et al.
Anti-Cancer Drugs|September 4, 2008
Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC statusNeil P Desai, Vuong Trieu, Larn Yuan Hwang, et al.
Pageof 20

Showing results (61-70 of 195) with videos related to

Sort By:
Pageof 20
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Individualizing treatment to optimize survival outcomes in breast cancerEdith A Perez, William J Gradishar, Christopher Twelves, et al.
Expert Review of Anticancer Therapy|September 12, 2015
Breast cancer and immunology: biomarker and therapeutic developmentsCesar A Santa-Maria, Sue Jung Park, Sarika Jain, et al.
Clinical Advances in Hematology & Oncology : H&O|May 30, 2014
Clinical roundtable monograph: effective management of quality of life in metastatic breast cancerTwelves Christopher, William J Gradishar, Joyce A O'Shaughnessy, et al.
The New England Journal of Medicine|September 26, 2008
Case records of the Massachusetts General Hospital. Case 30-2008. A 47-year-old woman with a mass in the breast and a solitary lesion in the spineWilliam J Gradishar, Jennifer R Bellon, Michele A Gadd, et al.
Oncology (Williston Park, N.Y.)|February 20, 2016
Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?Cesar Augusto Santa-Maria, Lauren Nye, Martin B Mutonga, et al.
Journal of Oncology Practice|November 28, 2012
Barriers to the use of personalized medicine in breast cancerChristine B Weldon, Julia R Trosman, William J Gradishar, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancerJulia R Trosman, Christine B Weldon, Julian C Schink, et al.
Cancer|September 10, 2008
Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancerHannah W Hazard, Seema R Gorla, Denise Scholtens, et al.
Journal of the National Cancer Institute|July 7, 2012
Clinical validity/utility, change in practice patterns, and economic implications of risk stratifiers to predict outcomes for early-stage breast cancer: a systematic reviewJohn Hornberger, Michael D Alvarado, Chien Rebecca, et al.
Anti-Cancer Drugs|September 4, 2008
Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC statusNeil P Desai, Vuong Trieu, Larn Yuan Hwang, et al.
Pageof 20